Alan Breau, Ph.D., has been appointed director of laboratory services at SNBL USA. Dr. Breau has 20 years of industry experience and will provide scientific and innovative oversight of SNBL’s scientific research for clients in the areas of flow cytometry, virology, formulations and analytical chemistry as well as other preclinical services.
 
Dr. Breau has more than 20 years of project team experience with early discovery and development projects. Prior to joining the company, he was the chief operating officer and co-founder of CRO Biologics Development Services and vice president of analytical services at MPI Research. He has also held various positions managing bioanalytical, analytical and immunology departments that provided analytical services for clients developing small molecules, large molecules and hybrid molecules such as antibody drug conjugates. 
 
“Alan has the perfect background and experience to direct SNBL USA’s laboratory services team,” said Dr. Thomas Beck, SNBL USA president and chief operating officer. “He will drive the vision and strategy for our laboratory services group and streamline efficiencies. With his scientific, industry and corporate experiences, Alan will provide an important new dimension as SNBL USA expands our support to the scientific priorities of our clients while meeting their laboratory services’ needs.”